Objectives:To evaluate the efficacy of shortduration, open-ended ureteral catheter drainage as a replacement to indwelling stent, and to study the effect of tamsulosin on stent-induced pain and storage symptoms following uncomplicated ureteroscopic removal of stones.Design: Prospective randomised study.Setting: School of Medical Sciences and Research, Sharda University, Greater Noida, India.
Patients:Patients who underwent ureteroscopic removal of stones for lower ureteral stones between November 2011 and January 2014 were randomly assigned into three groups. Patients in group 1 (n=33) were stented with 5-French double J stent for 2 weeks. Patients in group 2 (n=35) were administered tablet tamsulosin 0.4 mg once daily for 2 weeks in addition to stenting, and those in group 3 (n=31) underwent 5-French open-ended ureteral catheter drainage for 48 hours.
Main outcome measures:All patients were evaluated for flank pain using visual analogue scale scores at days 1, 2, 7, and 14, and for storage (irritative) bladder symptoms using International Prostate Symptom Score on days 7 and 14, and for quality-of-life score (using International Prostate Symptom Score) on day 14.Comparison of efficacy and tolerance of shortduration open-ended ureteral catheter drainage and tamsulosin administration to indwelling double J stents following ureteroscopic removal of stones New knowledge added by this study • This study shows that short-duration (up to 48 hours) ureteral drainage following ureteroscopic removal of stones (URS) has better efficacy and tolerance than indwelling stent placement with respect to the need for postoperative drainage. Hence, this can be a replacement for double J stenting.• Routine tamsulosin administration in patients with indwelling stents following URS has beneficial effects not only on irritative bladder symptoms but also on flank pain (both persistent and voiding). Implications for clinical practice or policy • Replacement of stents with short-duration open-ended ureteral catheter drainage provides early and more rehabilitation to the patients following URS. This is a viable option because there is no need for follow-up for stent-related symptoms, or maintaining records for planning its removal (no lost or retained stents).• It avoids a second invasive endoscopic procedure of stent removal, thereby reducing the medical and financial burden on the patient (especially important in developing countries). Patients are more likely to undergo URS again if required in the future (with stone recurrence) than opt for less effective or expensive choices like medical management, shock wave lithotripsy, or alternative forms of medicine.• In stented patients, tamsulosin administration improves the overall quality of life, and makes the period with stent in situ more bearable and asymptomatic.